GRAS2 - Overview: Grass Panel # 2, Serum
Establishing a diagnosis of an allergy to Bahia, Bermuda, Johnson, June/Kentucky blue, rye, and timothy Defining the allergen responsible for eliciting signs and symptoms Identifying allergens: -Responsible for allergic response and/or...
GRAS3 - Overview: Grass Panel # 3, Serum
Establishing a diagnosis of an allergy to cultivated rye, rye, sweet vernal, timothy, and velvet leaf Defining the allergen responsible for eliciting signs and symptoms Identifying allergens: -Responsible for allergic response and/or...
GRAS1 - Overview: Grass Panel # 1, Serum
Establishing a diagnosis of an allergy to June/Kentucky blue, meadow fescue, orchard, rye, and timothy Defining the allergen responsible for eliciting signs and symptoms Identifying allergens: -Responsible for allergic response and/or...
CCPQ - Overview: P/Q-Type Calcium Channel Antibody, Serum
Confirming a diagnosis of Lambert-Eaton syndrome Implicating autoimmunity as a disease-causing mechanism in patients with complex neurologic presentations, particularly in those with a history of cancer Implicating autoimmunity as the...
CRT24 - Overview: Creatinine, 24 Hour, Urine
Urinary creatinine, in conjunction with serum creatinine, is used to calculate the creatinine clearance, a measure of renal function Normalizing urinary analytes to account for the variation in urinary concentration
TGII - Overview: Thyroglobulin, Interference Interpretation
Interpretation for the evaluation of suspected interference from heterophile antibodies causing a falsely elevated thyroglobulin result
KRABZ - Overview: Krabbe Disease, Full Gene Analysis and Large (30 kb) Deletion, Varies
Second-tier test for confirming a diagnosis of Krabbe disease Carrier testing for individuals with a family history of Krabbe disease in the absence of known sequence variants in the family
ADPKP - Overview: Focused Autosomal Dominant Polycystic Kidney Disease Gene Panel, Varies
Providing a genetic evaluation for patients with a personal or family history suggestive of autosomal dominant polycystic kidney disease Establishing a diagnosis of autosomal dominant polycystic kidney disease
LQTSG - Overview: Long QT Syndrome Gene Panel, Varies
Providing a genetic evaluation for patients with a personal or family history suggestive of long QT syndrome (LQTS) Establishing a diagnosis of LQTS
NCDA - Overview: Congenital Dyserythropoietic Anemia Gene Panel, Next-Generation Sequencing, Varies
Confirming the diagnosis or carrier variant status of genes associated with congenital dyserythropoietic anemia Identifying variants within genes associated with phenotypic severity, allowing for predictive testing and further genetic...
Primary ciliary dyskinesia - Insights
Learn more about Mayo Clinic Laboratories’ robust approach to testing for primary ciliary dyskinesia, a rare genetic condition that can lead to chronic otosinopulmonary disease and infertility in men....
https://www.mayocliniclabs.com/it-mmfiles/cpt-code-changes.xlsx
note, CPT Code changes listed on this document are effective January 1st, 2025.*** ***Updates and other changes may occur, and be reflected on this document, leading up to 2025*** ***CPT Code Updates...
CPT Codes and LOINC Update: September 2019 - Insights
View a full list of new CPT codes, Test Classification Updates, LOINC Codes, and Z-Codes posted to mayocliniclabs.com during the month of September 2019....
MCL Primary Ciliary Dyskinesia Genetic Testing Patient Information MC1235297
MCL Primary Ciliary Dyskinesia Genetic Testing Patient Information Complete print Reset Form Primary Ciliary Dyskinesia Genetic Testing Patient Information Instructions Accurate interpretation reporting...
New communication process for CPT Code changes - Insights
Mayo Clinic Laboratories (MCL) is pleased to announce an essential update to our CPT code communication process and website layout. This change is designed to bring timely notifications for accurate billing...